Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

London Stock Exchange Group Plc (LSE.LN)

London Stock Exchange Group Plc (LSE.LN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LSE.LN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
8,498.240 +1.43%
on 01/28/21
9,358.000 -7.89%
on 01/11/21
-258.000 (-2.91%)
since 12/24/20
3-Month
7,586.000 +13.63%
on 11/24/20
9,358.000 -7.89%
on 01/11/21
+292.000 (+3.51%)
since 10/28/20
52-Week
5,300.000 +62.64%
on 03/18/20
9,358.000 -7.89%
on 01/11/21
+888.000 (+11.48%)
since 01/28/20

Most Recent Stories

More News
3 Top Growth Stocks I'd Buy Right Now Without Any Hesitation

Recession fears and high interest rates can't keep these profitable growth stars down.

MSFT : 266.73 (-0.31%)
LSE.LN : 8,620.000 (-0.58%)
ASML : 662.79 (-2.35%)
TMUS : 143.81 (+0.57%)
Why Microsoft Is Rising Today

The tech giant made a high-profile cloud deal with the London Stock Exchange and was hailed as a "top" idea at Credit Suisse.

CS : 3.58 (-0.83%)
TRI : 117.26 (-0.52%)
BX : 94.62 (-2.16%)
MSFT : 266.73 (-0.31%)
LSE.LN : 8,620.000 (-0.58%)
AIM ImmunoTech Announces Clinical Trial Agreement for a Phase 2a Human Challenge Trial of Ampligen as a Potential Intranasal Prophylaxis Against Respiratory Viruses

The governing ethics committee and regulatory agency have met on the study protocol and plan to issue their response in Q4; AIM anticipates that the trial will commence shortly thereafter

LSE.LN : 8,620.000 (-0.58%)
AIM : 0.5796 (-4.67%)
ORPH : 0.8700 (-2.25%)
TransGlobe Energy Corporation Operations Update

AIM & TSX: “TGL” & NASDAQ: “TGA”

TGL.TO : 5.06 (-0.39%)
TGA : 3.72 (+7.83%)
LSE.LN : 8,620.000 (-0.58%)
EF Hutton Expands Investment Banking Capabilities with Mr. de Alejo’s Appointment as Managing Director, ESG Investment Banking

New York, NY, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton today announced a new addition to its Investment Bank franchise to help corporate clients as they transform their businesses...

LSE.LN : 8,620.000 (-0.58%)
Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Conference

Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Conference

LSE.LN : 8,620.000 (-0.58%)
SLN : 12.98 (+0.08%)
Preliminary Results for the Year ended 30 June 2021

LSE.LN : 8,620.000 (-0.58%)
Caledonia Mining Corporation Plc: Caledonia acquires the 940,000 oz Maligreen project in Zimbabwe

ST HELIER, Jersey, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: CMCL) is pleased to announce that it has entered...

LSE.LN : 8,620.000 (-0.58%)
Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes

A recor Therapeutics plc (“Arecor”, the “Company” or the “Group”)

LSE.LN : 8,620.000 (-0.58%)
AREC : 1.5200 (-10.06%)
Mine development underway at Coringa

For immediate release

LSE.LN : 8,620.000 (-0.58%)
SBI.TO : 0.55 (-5.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 8,859.013
2nd Resistance Point 8,762.507
1st Resistance Point 8,691.253
Last Price 8,620.000
1st Support Level 8,523.493
2nd Support Level 8,426.987
3rd Support Level 8,355.733

See More

52-Week High 9,358.000
Last Price 8,620.000
Fibonacci 61.8% 7,807.844
Fibonacci 50% 7,329.000
Fibonacci 38.2% 6,850.156
52-Week Low 5,300.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar